FMR CORP 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 2,695,007 2.500% |
-8,426,644 (-75.77%) |
Filing |
| 2024-11-12 10:32 am Sale |
2024-11-08 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 11,121,651 10.525% |
-336,043 (-2.93%) |
Filing |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 11,457,694 11.905% |
-571,095 (-4.75%) |
Filing |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 12,028,789 12.701% |
1,066,820 (+9.73%) |
Filing |
| 2022-02-09 09:19 am Sale |
2022-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 10,961,969 13.456% |
-1,061,615 (-8.83%) |
Filing |
| 2021-02-08 10:25 am Purchase |
2021-02-05 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 12,023,584 14.999% |
5,698,929 (+90.11%) |
Filing |